A Double-blind, Randomized, Placebo-controlled, Three-way Crossover Study to Investigate the Drug-Drug Interactions of Brivaracetam and Ethanol in Healthy Male Subjects.

Trial Profile

A Double-blind, Randomized, Placebo-controlled, Three-way Crossover Study to Investigate the Drug-Drug Interactions of Brivaracetam and Ethanol in Healthy Male Subjects.

Completed
Phase of Trial: Phase I

Latest Information Update: 09 Dec 2014

At a glance

  • Drugs Brivaracetam (Primary) ; Alcohol
  • Indications Epilepsy; Myoclonic epilepsies; Neurological disorders; Pain; Postherpetic neuralgia
  • Focus Pharmacodynamics
  • Sponsors UCB Pharma SA
  • Most Recent Events

    • 14 Nov 2012 New trial record
    • 01 Nov 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top